KASSIE HALL: Open Payments
NPI 1023605474 · CLIFTON FORGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$968 in 53 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,140 · 2025 $968
Food & beverage: $968
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $266 |
| Otsuka America Pharmaceutical, Inc. | 10 | $152 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Lilly USA, LLC | 5 | $81 |
| Novo Nordisk Inc | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| Amgen Inc. | 3 | $46 |
| Exact Sciences Corporation | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Ascendis Pharma Endocrinology Inc | 2 | $33 |
Products named: REXULTI, VRAYLAR, UBRELVY, MOUNJARO, BREZTRI, XIFAXAN, QULIPTA, OTEZLA.
Industry payments across VA — which companies pay providers there.
